Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Cardiac experimental biology and translational research would benefit from an in vitro surrogate for human heart muscle. This study investigated structural and functional properties and interventional responses of human engineered cardiac tissues (hECTs) compared to human myocardium. Human embryonic stem cell‐derived cardiomyocytes (hESC‐CMs, >90% troponin‐positive) were mixed with collagen and cultured on force‐sensing elastomer devices. hECTs resembled trabecular muscle and beat spontaneously (1.18±0.48 Hz). Microstructural features and mRNA expression of cardiac‐specific genes ( α‐MHC, SERCA2a, and ACTC1 ) were comparable to human myocardium. Optical mapping revealed cardiac refractoriness with loss of 1:1 capture above 3 Hz, and cycle length dependence of the action potential duration, recapitulating key features of cardiac electrophysiology. hECTs reconstituted the Frank‐Starling mechanism, generating an average maximum twitch stress of 660 μN/mm 2 at L max , approaching values in newborn human myocardium. Dose‐response curves followed exponential pharmacodynamics models for calcium chloride (EC 50 1.8 mM) and verapamil (IC 50 0.61 μM); isoproterenol elicited a positive chronotropic but negligible inotropic response, suggesting sarcoplasmic reticulum immaturity. hECTs were amenable to gene transfer, demonstrated by successful transduction with Ad.GFP. Such 3‐D hECTs recapitulate an early developmental stage of human myocardium and promise to offer an alternative preclinical model for cardiology research.—Turnbull, I. C., Karakikes, I., Serrao, G. W., Backeris, P., Lee, J.‐J., Xie, C., Senyei, G., Gordon, R. E., Li, R. A., Akar, F. G., Hajjar, R. J., Hulot, J.‐S., Costa, K. D. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. FASEB J. 28, 644–654 (2014). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“but not pressure- and volume-based metrics directly representing pump performance of the heart”
From Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells (2018) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, we have reported a linear relationship between the developed stress and axial stretch in hvCTS [14].”
From Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells (2018) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The weak response is thought to be due to immature adrenergic and Ca2+ signaling pathways such as lowered phospholamban expression compared to their adult counterparts [14].”
From Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells (2018) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Functionally, we observed an augmented sensitivity of the hvCOC to adrenergic stimulation and the presence of both chronotropic and inotropic effects when compared with the hvCTS and hvCMT systems constructed with the same hPSC-vCMs [14,18].”
From Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells (2018) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the construction of tissues, specifically engineered 3D mimics, often necessitates the addition of stromal cells to facilitate proper formation of these tissue constructs.32,33”
From Single-cell RNA sequencing reveals maturation trajectory in human pluripotent stem cell-derived cardiomyocytes in engineered tissues (2023) · cites this paper as [32]
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characterization and Enrichment of Cardiomyocytes Derived From Human Embryonic Stem Cells
Xu, C., Police, S., Rao, N., & Carpenter, M. K. (2002) · Circulation Research · doi:10.1161/01.res.0000035254.80718.91 · Cited by 902 · cited 1×
“the response to pharmacologic agents (49), strategies”
Engler, A. J., Carag-Krieger, C., Johnson, C. P., Raab, M., Tang, H.-Y., Speicher, D. W., Sanger, J. W., Sanger, J. M., & Discher, D. E. (2008) · Journal of Cell Science · doi:10.1242/jcs.029678 · Cited by 865 · cited 1×
“cardiomyocyte function and maturation (3, 4).”
A protocol for rapid generation of recombinant adenoviruses using the AdEasy system
Luo, J., Deng, Z.-L., Luo, X., Tang, N., Song, W.-X., Chen, J., Sharff, K. A., Luu, H. H., Haydon, R. C., Kinzler, K. W., et al. (2007) · Nature Protocols · doi:10.1038/nprot.2007.135 · Cited by 854
Feeder-independent culture of human embryonic stem cells
Ludwig, T. E., Bergendahl, V., Levenstein, M. E., Yu, J., Probasco, M. D., & Thomson, J. A. (2006) · Nature Methods · doi:10.1038/nmeth902 · Cited by 681 · cited 1×
“All experiments used cells derived from the HES2 hESC line (Wicell, Madison, WI, USA) propagated in feeder-free culture, as described previously (20).”
MethodGrowth of engineered human myocardium with mechanical loading and vascular coculture
Tulloch, N. L., Muskheli, V., Razumova, M. V., Korte, F. S., Regnier, M., Hauch, K. D., Pabon, L., Reinecke, H., & Murry, C. E. (2011) · Circulation Research · doi:10.1161/circresaha.110.237206 · Cited by 666 · cited 3×
“Since nonmyocytes can substantially affect cardiac cells (6, 16, 25, 26, 28), generation of human ECTs using well-defined cell populations is critical for studying the effects of heterocellular interactions on hECT viability, maturation, and function under controlled conditions.”
BackgroundMetabolic Gene Expression in Fetal and Failing Human Heart
Razeghi, P., Young, M. E., Alcorn, J. L., Moravec, C. S., Frazier, O. H., & Taegtmeyer, H. (2001) · Circulation · doi:10.1161/hc4901.100526 · Cited by 616 · cited 1×
“Interestingly, a 10 increase in ANF mRNA expression was also reported for human fetal heart compared to nonfailing adult heart mRNA (31).”
BackgroundZhang, D., Shadrin, I. Y., Lam, J., Xian, H.-Q., Snodgrass, H. R., & Bursac, N. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.026 · Cited by 565 · cited 7×
“(9) showed that as hESC-CM purity increased from 48 to 90%, conduction velocity increased, while the contractile force per myocyte decreased, and other factors such as APD and maximum active force were not significantly affected by hESC-CM purity.”
BackgroundInfluentialTissue engineering of vascularized cardiac muscle from human embryonic stem cells
Caspi, O., Lesman, A., Basevitch, Y., Gepstein, A., Arbel, G., Habib, I. H. M., Gepstein, L., & Levenberg, S. (2007) · Circulation Research · doi:10.1161/01.res.0000257776.05673.ff · Cited by 558 · cited 1×
“Important advances have been made toward developing human engineered cardiac tissues (hECTs) as patches for myocardial repair, using biodegradable scaffolds (2, 8), fibrin-based hydrogels (9), or scaffoldfree constructs (10, 11).”
BackgroundDevelopment of a drug screening platform based on engineered heart tissue
Hansen, A., Eder, A., Bönstrup, M., Flato, M., Mewe, M., Schaaf, S., Aksehirlioglu, B., Schwörer, A., Uebeler, J., & Eschenhagen, T. (2010) · Circulation Research · doi:10.1161/circresaha.109.211458 · Cited by 510 · cited 1×
“We (22) and others (15, 32) have developed PDMS culture devices based on a simple beam-bending principle for optically monitoring forces generated by engineered tissues in a sterile, temperature-controlled environment.”
BackgroundFranz, M. R., Swerdlow, C. D., Liem, L. B., & Schaefer, J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113706 · Cited by 457 · cited 1×
“7C), comparable to measurements in human myocardium (48).”
Background
Cited by
Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications
Mathur, A., Loskill, P., Shao, K., Huebsch, N., Hong, S., Marcus, S. G., Marks, N., Mandegar, M., Conklin, B. R., Lee, L. P., et al. (2015) · Scientific Reports · doi:10.1038/srep08883 · Cited by 519
Ruan, J.-L., Tulloch, N. L., Razumova, M. V., Saiget, M., Muskheli, V., Pabon, L., Reinecke, H., Regnier, M., & Murry, C. E. (2016) · Circulation · doi:10.1161/circulationaha.114.014998 · Cited by 467
Marsano, A., Conficconi, C., Lemme, M., Occhetta, P., Gaudiello, E., Votta, E., Cerino, G., Redaelli, A., & Rasponi, M. (2016) · Lab on a Chip · doi:10.1039/c5lc01356a · Cited by 447
Shadrin, I. Y., Allen, B. W., Qian, Y., Jackman, C. P., Carlson, A. L., Juhas, M. E., & Bursac, N. (2017) · Nature Communications · doi:10.1038/s41467-017-01946-x · Cited by 420
Tissue Engineering Approaches in the Design of Healthy and Pathological In Vitro Tissue Models
Caddeo, S., Boffito, M., & Sartori, S. (2017) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00040 · Cited by 285
Differentiation of cardiomyocytes and generation of human engineered heart tissue
Breckwoldt, K., Letuffe-Brenière, D., Mannhardt, I., Schulze, T., Ulmer, B., Werner, T., Benzin, A., Klampe, B., Reinsch, M. C., Laufer, S., et al. (2017) · Nature Protocols · doi:10.1038/nprot.2017.033 · Cited by 272
Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model
Riegler, J., Tiburcy, M., Ebert, A., Tzatzalos, E., Raaz, U., Abilez, O. J., Shen, Q., Kooreman, N. G., Neofytou, E., Chen, V. C., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.306985 · Cited by 258
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues
Feric, N. T., & Radisic, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.019 · Cited by 247
A tissue-engineered scale model of the heart ventricle
MacQueen, L. A., Sheehy, S. P., Chantre, C. O., Zimmerman, J. F., Pasqualini, F. S., Liu, X., Goss, J. A., Campbell, P. H., Gonzalez, G. M., Park, S.-J., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0271-5 · Cited by 227
Hayakawa, T., Kunihiro, T., Ando, T., Kobayashi, S., Matsui, E., Yada, H., Kanda, Y., Kurokawa, J., & Furukawa, T. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.09.010 · Cited by 198
Leonard, A., Bertero, A., Powers, J. D., Beussman, K. M., Bhandari, S., Regnier, M., Murry, C. E., & Sniadecki, N. J. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.03.016 · Cited by 193
“As observed by others [41], the EHTs within each group generated higher twitch forces under isometric conditions compared to auxotonic contractions.”
Dynamic culture yields engineered myocardium with near-adult functional output
Jackman, C. P., Carlson, A. L., & Bursac, N. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.024 · Cited by 188
In vitro cardiac tissue models: Current status and future prospects
Mathur, A., Ma, Z., Loskill, P., Jeeawoody, S., & Healy, K. E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.011 · Cited by 187
“However, an insufficient response to isoproterenol suggested cardiac tissue immaturity [83].”
BackgroundLi, R. A., Keung, W., Cashman, T. J., Backeris, P. C., Johnson, B. V., Bardot, E. S., Wong, A. O. T., Chan, P. K. W., Chan, C. W. Y., & Costa, K. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.024 · Cited by 175
“3f), similar to the negative Ca2+ transient-frequency data in hvCMs [24] and negative force-frequency relationships observed for hvCMT [18], hvCTS [14] and newborn human heart muscle [30], as commonly seen with engineered heart tissues.”
BackgroundMethodResultSelf-citationMayourian, J., Ceholski, D. K., Gorski, P. A., Mathiyalagan, P., Murphy, J. F., Salazar, S. I., Stillitano, F., Hare, J. M., Sahoo, S., Hajjar, R. J., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.312420 · Cited by 168
Self-citationBasara, G., Saeidi-Javash, M., Ren, X., Bahcecioglu, G., Wyatt, B. C., Anasori, B., Zhang, Y., & Zorlutuna, P. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.12.033 · Cited by 162
Smith, A. S. T., Macadangdang, J. R., Leung, W. W., Laflamme, M. A., & Kim, D. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.002 · Cited by 169
“Typically, cells are suspended in a scaffold matrix cultured within a platform that infers directionaland structuralparameters upon the developing tissue (Liau et al., 2011; Turnbull et al., 2014; van (Tandon et al., 2011).”
Engineering of human cardiac muscle electromechanically matured to an adult-like phenotype
Ronaldson-Bouchard, K., Yeager, K., Teles, D., Chen, T., Ma, S., Song, L., Morikawa, K., Wobma, H. M., Vasciaveo, A., Ruiz, E. C., et al. (2019) · Nature Protocols · doi:10.1038/s41596-019-0189-8 · Cited by 144
Direct 3D bioprinting of cardiac micro-tissues mimicking native myocardium
Liu, J., Miller, K. L., Ma, X., Dewan, S., Lawrence, N., Whang, G. J., Chung, P., McCulloch, A. D., & Chen, S. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120204 · Cited by 151
“Whereas most works rely on the self-alignment of cardiomyocytes encapsulated in extracellular matrix around stiff cantilevers [6,8,31,32] and 3D printing studies have been limited to log pile structures [40,41], this is the first instance in which the effects of directly patterning various 3D microstructures on”
BackgroundHartman, M. E., Dai, D.-F., & Laflamme, M. A. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.004 · Cited by 138
“Engineered human cardiac tissues made of human ESC-derived cardiomyocytes mixed with collagen and cultured on three dimensional elastomeric devices exhibit microstructural features, mRNA expression, and electromechanical properties comparable to neonatal human myocardium [118].”
BackgroundNatural Biomaterials for Cardiac Tissue Engineering: A Highly Biocompatible Solution
Majid, Q. A., Fricker, A. T. R., Gregory, D. A., Davidenko, N., Hernandez Cruz, O., Jabbour, R. J., Owen, T. J., Basnett, P., Lukasiewicz, B., Stevens, M., et al. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.554597 · Cited by 131
“EHTs of micro-dimensions based on collagen type I (31) or a mixture of collagen I and Matrigel with human embryonic stem cell-derived cardiomyocytes were also used as cardiac models for preclinical drug screening (32).”
MethodBliley, J. M., Vermeer, M. C. S. C., Duffy, R. M., Batalov, I., Kramer, D., Tashman, J. W., Shiwarski, D. J., Lee, A., Teplenin, A. S., Volkers, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd1817 · Cited by 134
Fibrous scaffolds for building hearts and heart parts
Capulli, A. K., MacQueen, L. A., Sheehy, S. P., & Parker, K. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.020 · Cited by 130
Sala, L., Bellin, M., & Mummery, C. L. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13577 · Cited by 121
“, 2015), engineered heart tissues (Zimmermann and Schneiderbanger, 2002; Turnbull et al., 2014) or 3D vascularized cardiac layers (Mosadegh et al.”
BackgroundFeinberg, A. W. (2015) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071114-040632 · Cited by 134
Masumoto, H., Nakane, T., Tinney, J. P., Yuan, F., Ye, F., Kowalski, W. J., Minakata, K., Sakata, R., Yamashita, J. K., & Keller, B. B. (2016) · Scientific Reports · doi:10.1038/srep29933 · Cited by 113
Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression
Turnbull, I. C., Eltoukhy, A. A., Fish, K. M., Nonnenmacher, M., Ishikawa, K., Chen, J., Hajjar, R. J., Anderson, D. G., & Costa, K. D. (2016) · Molecular Therapy · doi:10.1038/mt.2015.193 · Cited by 112
Self-citationPhysical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes
Zhu, R., Blazeski, A., Poon, E., Costa, K. D., Tung, L., & Boheler, K. R. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt507 · Cited by 110
“2014 [13] Suspension EB Expression of cardiac genes approached levels in adult LV myocardium in engineered cardiac tissues”
BackgroundSelf-citationBiology of the cardiac myocyte in heart disease
Peter, A. K., Bjerke, M. A., & Leinwand, L. A. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-01-0038 · Cited by 128
Ma, Z., Huebsch, N., Koo, S., Mandegar, M. A., Siemons, B., Boggess, S., Conklin, B. R., Grigoropoulos, C. P., & Healy, K. E. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0280-4 · Cited by 109
Biomaterializing the promise of cardiac tissue engineering
Pomeroy, J. E., Helfer, A., & Bursac, N. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.009 · Cited by 107
Zhang, W., Kong, C., Tống, M. P., Chooi, W. H., Huang, N., Li, R. A., & Chan, B. P. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.058 · Cited by 120
Self-citationCashman, T. J., Josowitz, R., Johnson, B. V., Gelb, B. D., & Costa, K. D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146697 · Cited by 101
Self-citationTowards chamber specific heart-on-a-chip for drug testing applications
Zhao, Y., Rafatian, N., Wang, E. Y., Wu, Q., Lai, B. F. L., Lu, R. X., Savoji, H., & Radisic, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.12.002 · Cited by 97
“[28, 39, 58] These templates can be a single wire[39], a single perfusable tube[54], double wires[28, 58], or opposing cantilevers[30, 31, 34, 59], residing in microwells (Figure 2B–F), where they simultaneously serve as tissue anchors and force sensors based on their mechanical properties.”
BackgroundWickramasinghe, N. M., Sachs, D. M., Shewale, B., Gonzalez, D. M., Dhanan-Krishnan, P., Torre, D., LaMarca, E. A., Raimo, S., Dariolli, R., Serasinghe, M. N., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.02.011 · Cited by 107
Self-citationAnisotropic silk biomaterials containing cardiac extracellular matrix for cardiac tissue engineering
Stoppel, W. L., Hu, D., Domian, I. J., Kaplan, D. L., & Black, L. D. (2015) · Biomedical Materials · doi:10.1088/1748-6041/10/3/034105 · Cited by 98
Anisotropic engineered heart tissue made from laser-cut decellularized myocardium
Schwan, J., Kwaczala, A. T., Ryan, T. J., Bartulos, O., Ren, Y., Sewanan, L. R., Morris, A. H., Jacoby, D. L., Qyang, Y., & Campbell, S. G. (2016) · Scientific Reports · doi:10.1038/srep32068 · Cited by 95
Stillitano, F., Hansen, J., Kong, C., Karakikes, I., Funck‐Brentano, C., Geng, L., Scott, S. A., Reynier, S., Ma, W., Valogne, Y., et al. (2017) · eLife · doi:10.7554/elife.19406 · Cited by 99
“Finally, further developments in differentiation protocols (Burridge et al., 2014), in functional maturation of iPSC-derived cells (Lundy et al., 2013) or in iPSC-based bioengineering (Schaaf et al., 2011; Turnbull et al., 2014) might also improve the overall predictability of the method.”
Self-citationSasaki, D., Matsuura, K., Seta, H., Haraguchi, Y., Okano, T., & Shimizu, T. (2018) · PLOS ONE · doi:10.1371/journal.pone.0198026 · Cited by 91
Kerscher, P., Turnbull, I. C., Hodge, A. J., Kim, J., Seliktar, D., Easley, C. J., Costa, K. D., & Lipke, E. A. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.011 · Cited by 88
Self-citationKeung, W., Boheler, K. R., & Li, R. A. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt406 · Cited by 87
“Unlike with adult CMs, however, increasing isoproterenol concentration produces no ionotropic response [28,29], once again demonstrating the immaturity of these cells.”
BackgroundSelf-citationThe electrophysiological development of cardiomyocytes
Liu, J., Laksman, Z., & Backx, P. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.023 · Cited by 106
Thomas, D., Cunningham, N. J., Shenoy, S., & Wu, J. C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab115 · Cited by 90
Mayourian, J., Ceholski, D. K., Gonzalez, D. M., Cashman, T. J., Sahoo, S., Hajjar, R. J., & Costa, K. D. (2018) · Circulation Research · doi:10.1161/circresaha.117.311589 · Cited by 80
“muscle physiology including ECC, the Frank–Starling mechanism, and pharmacological responses.(162) Such hECTs can be”
BackgroundSelf-citationHuman iPSC modeling of heart disease for drug development
Hnatiuk, A. P., Briganti, F., Staudt, D., & Mercola, M. A. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.02.016 · Cited by 82
Genomic correction of familial cardiomyopathy in human engineered cardiac tissues
Stillitano, F., Turnbull, I. C., Karakikes, I., Nonnenmacher, M., Backeris, P., Hulot, J.-S., Kranias, E. G., Hajjar, R. J., & Costa, K. D. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw307 · Cited by 77
“moulds, with integrated cantilever end-posts for non-invasive measurement of contractile function.(5)”
BackgroundSelf-citationCasini, S., Verkerk, A. O., & Remme, C. A. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6735-0 · Cited by 83
“For this, hiPSC-CMs can be loaded for instance with the voltage-sensitive dye di-4-ANEPPS [93].”
MethodBielawski, K. S., Leonard, A., Bhandari, S., Murry, C., & Sniadecki, N. J. (2016) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2016.0257 · Cited by 74
“8,9,12,13 19 The three-dimensional environment recapitulates the cell–cell and cell–matrix interactions of the native myocardium, promoting hiPSC-CMs to have elon-gated shapes and a higher degree of myofibril organization.”
Human induced pluripotent stem cell-derived fiber-shaped cardiac tissue on a chip
Morimoto, Y., Mori, S., Sakai‐Takemura, F., & Takeuchi, S. (2016) · Lab on a Chip · doi:10.1039/c6lc00422a · Cited by 71
Yamagishi, H., Srivastava, D., Keller, B. B., Hs, B., Markwald, R. R., & Nakanishi, T. (2016) · Springer eBooks · doi:10.1007/978-4-431-54628-3 · Cited by 69
Kijlstra, J. D., Hu, D., Mittal, N., Kausel, E., van der Meer, P., Garakani, A., & Domian, I. J. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.10.017 · Cited by 65
“Verapamil is an L-type calcium channel blocker that has been shown to decrease CM contractility (Dolnikov et al., 2006; Turnbull et al., 2014).”
BackgroundResultInfluentialLee, E. K., Tran, D. D., Keung, W., Chan, P., Wong, G., Chan, C. W., Costa, K. D., Li, R. A., & Khine, M. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.09.008 · Cited by 63
“9 mg/mL), and human foreskin fibroblasts (100,000 cells per strip) as previously described (Turnbull et al., 2014).”
BackgroundMethodInfluentialSelf-citationKurokawa, Y. K., & George, S. C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.004 · Cited by 59
Kerscher, P., Kaczmarek, J. A., Head, S. E., Ellis, M. E., Seeto, W. J., Kim, J., Bhattacharya, S., Suppiramaniam, V. D., & Lipke, E. A. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00226 · Cited by 61
Rapid 3D BioPrinting of a human iPSC-derived cardiac micro-tissue for high-throughput drug testing
Miller, K. L., Xiang, Y., Yu, C., Pustelnik, J., Wu, J. C., Ma, X., Matsui, T., Imahashi, K., & Chen, S. (2021) · Organs-on-a-Chip · doi:10.1016/j.ooc.2021.100007 · Cited by 64
“Although not statistically significant, SERCA2a displayed an upward trend in expression level similar to other 3D heart tissues (Mannhardt et al., 2016; Kranias and Hajjar, 2012; Rao et al., 2013; Turnbull et al., 2014) (Fig.”
ResultStaubli, S. M., Cerino, G., de Torre, I. G., Alonso, M., Oertli, D., Eckstein, F. S., Glatz, K., Rodríguez‐Cabello, J. C., & Marsano, A. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.047 · Cited by 56
“cartilage, myocardium) [1-2] has significantly progressed in the past years starting by choosing a suitable biomaterial and a competent cell type.”
BackgroundKeung, W., Chan, P. K. W., Backeris, P. C., Lee, E. K., Wong, N., Wong, A. O. T., Wong, G. K. Y., Chan, C. W. Y., Fermini, B., Costa, K. D., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1385 · Cited by 54
“After 48 hours, cells were fabricated into hvCTS as previous described.(35,50) At 7 days after creation, the hvCTS were used for drug screening.”
BackgroundMethodSelf-citationHuman cardiac tissue engineering: from pluripotent stem cells to heart repair
Jackman, C. P., Shadrin, I. Y., Carlson, A. L., & Bursac, N. (2015) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2014.11.004 · Cited by 54
Nemec, M. J., Kim, H., Marciante, A. B., Barnes, R. C., Talcott, S. T., & Mertens‐Talcott, S. U. (2016) · Food & Function · doi:10.1039/c6fo00636a · Cited by 56
Kofron, C. M., & Mende, U. (2017) · The Journal of Physiology · doi:10.1113/jp273100 · Cited by 60
Engineered Macroscale Cardiac Constructs Elicit Human Myocardial Tissue-like Functionality
Valls-Margarit, M., Iglesias‐García, O., Guglielmo, C. D., Sarlabous, L., Tadevosyan, K., Paoli, R., Comelles, J., Blanco-Almazán, D., Jiménez‐Delgado, S., Castillo‐Fernández, Ó., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.05.024 · Cited by 57
“Such microtissues are usually fabricated by using cell-laden naturalbased hydrogels cast on posts (Fennema et al., 2013; Hinson et al., 2015; Huebsch et al., 2016; Kensah et al., 2013; Ruan et al., 2016; Schaaf et al., 2011; Soong et al., 2012; Thavandiran et al., 2013; Tiburcy et al., 2017; Turnbull et al., 2014; Zha…”
BackgroundPoon, E., Keung, W., Liang, Y., Ramalingam, R., Yan, B., Zhang, S., Chopra, A., Moore, J., Herren, A., Lieu, D. K., et al. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.000918 · Cited by 52
“For contraction, as anticipated from their level of mechanical activities, hESC-VCMs had the lowest levels of sarcomeric proteins such as β-myosin heavy chain (MYH7) and α-actin (ACTA1), followed by hF-VCMs, and then hA-VCMs, potentially underlying the weaker developed twitch force of engineered ventricular tissue str…”
BackgroundSelf-citationExtracellular Vesicles in Cardiac Regeneration: Potential Applications for Tissues-on-a-Chip
Wagner, K. T., Nash, T. R., Liu, B., Vunjak‐Novakovic, G., & Radisic, M. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.08.005 · Cited by 53
Low-Toxicity Diindol-3-ylmethanes as Potent Antifouling Compounds
Wang, K., Xu, Y., Lu, L., Li, Y., Han, Z., Zhang, J., Shao, C., Wang, C., & Qian, P. (2015) · Marine Biotechnology · doi:10.1007/s10126-015-9656-6 · Cited by 48
Engineering approaches for cardiac organoid formation and their characterization
Joddar, B., Natividad-Diaz, S. L., Padilla, A. E., Esparza, A., Ramirez, S. P., Chambers, D. R., & Ibaroudene, H. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.009 · Cited by 51
Wei, X., Zhuang, L., Li, H., He, C., Wan, H., Hu, N., & Wang, P. (2020) · Small · doi:10.1002/smll.202005828 · Cited by 50
Vila, A., Torras, N., Castaño, A. G., García-Díaz, M., Comelles, J., Pérez, T., Corregidor, C., Castaño, Ó., Engel, E., Fernández‐Majada, V., et al. (2019) · Biofabrication · doi:10.1088/1758-5090/ab5f50 · Cited by 54
Precision Medicine and cardiac channelopathies: when dreams meet reality
Gnecchi, M., Sala, L., & Schwartz, P. J. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab007 · Cited by 46
Tamargo, M. A., Nash, T. R., Fleischer, S., Kim, Y., Vila, O. F., Yeager, K. J., Summers, M., Zhao, Y., Lock, R. I., Chavez, M., et al. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c01006 · Cited by 49
Engineering the maturation of stem cell-derived cardiomyocytes
Hong, Y., Zhao, Y., Li, H., Yang, Y., Chen, M., Wang, X., Luo, M., & Wang, K. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1155052 · Cited by 48
“under the stretch of 20% cell length (Turnbull et al., 2014), while another study reported an MCF of 0.”
BackgroundXu, F., Jin, H., Liu, L., Yang, Y., Cen, J., Wu, Y., Chen, S., & Sun, D. (2024) · Microsystems & Nanoengineering · doi:10.1038/s41378-024-00692-7 · Cited by 45
“…demonstrated that cardiomyocytes subjected to suitable mechanical stimulation were morphologically more mature (larger, more facilitated cell alignment, longer sarcomere, Cx43 polarization) and showed a signi fi cant increase in ion channel protein expression and mechanical properties 92 – 97 .”
BackgroundSignaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation
Parikh, A., Wu, J., Blanton, R. M., & Tzanakakis, E. S. (2015) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2014.0662 · Cited by 45
“Differentiation can be further enhanced in 3D cultures by culturing cells in bovine (type I) collagen/Matrigel hydrogels yielding cells (2–3 weeks) expressing cardiac genes at comparable levels to the adult left ventricle.(159) Fibrin-based hydrogels, biodegradable scaffolds, and scaffold-free constructs have also bee…”
BackgroundChen, G., Li, S., Karakikes, I., Ren, L., Zi-Ying Chow, M., Chopra, A., Keung, W., Yan, B., Chan, C. W. Y., Costa, K. D., et al. (2015) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002049 · Cited by 38
“These results were in complete accordance with our recent report that human ventricular cardiac tissue strips that are ≈10 mm consisting of ≈10(6) cells per tissue elicit a positive chronotropic but negligible inotropic response as gauged by their twitch forces on β-adrenergic stimulation by isoproterenol.(19) Consist…”
ResultSelf-citationResident Macrophages and Their Potential in Cardiac Tissue Engineering
Suku, M., Forrester, L. M., Biggs, M. J. P., & Monaghan, M. G. (2022) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2021.0036 · Cited by 44
“to facilitate fabrication of potential preclinical in vitro myocardium models.(55) Another interesting modification to the EHT came with the use of a surgical suture within PDMS molds to obtain aligned cardiac tissues with striations called ‘‘Biowire.”
MethodEngineering and Assessing Cardiac Tissue Complexity
Tadevosyan, K., Iglesias‐García, O., Mazo, M. M., Prósper, F., & Raya, Á. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031479 · Cited by 36
“The mechanical force exerted by contracting CMs can be measured in single cells as well as in whole ECT constructs [36,42,47,48,50,57,100].”
BackgroundInfluentialAbi‐Gerges, N., Pointon, A., Oldman, K. L., Brown, M. R., Pilling, M. A., Sefton, C. E., Garside, H., & Pollard, C. E. (2016) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2016.09.001 · Cited by 36
Modeling the Human Scarred Heart In Vitro: Toward New Tissue Engineered Models
Deddens, J. C., Sadeghi, A. H., Hjortnaes, J., Laake, L. W. V., Buijsrogge, M. P., Doevendans, P. A., Khademhosseini, A., & Sluijter, J. P. G. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600571 · Cited by 33
Pagnotta, G., Kalia, S., Lisa, L. D., Cicero, A. F. G., Borghi, C., & Focarete, M. L. (2022) · Bioprinting · doi:10.1016/j.bprint.2022.e00218 · Cited by 34
Shahin‐Shamsabadi, A., & Selvaganapathy, P. R. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.024 · Cited by 34
Jeziorowska, D., Fontaine, V., Jouve, C., Villard, E., Dussaud, S., Akbar, D., Letang, V., Cervello, P., Itier, J.-M., Pruniaux, M., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061173 · Cited by 36
Self-citationCardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies
Seguret, M., Vermersch, E., Jouve, C., & Hulot, J. (2021) · Biomedicines · doi:10.3390/biomedicines9050563 · Cited by 33
Self-citationBioengineering Strategies to Create 3D Cardiac Constructs from Human Induced Pluripotent Stem Cells
Varzideh, F., Mone, P., & Santulli, G. (2022) · Bioengineering · doi:10.3390/bioengineering9040168 · Cited by 32
Multiparametric Mechanistic Profiling of Inotropic Drugs in Adult Human Primary Cardiomyocytes
Abi‐Gerges, N., Indersmitten, T., Truong, K., Nguyen, W., Ratchada, P., Nguyen, N., Page, G., Miller, P. E., & Ghetti, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-64657-2 · Cited by 30
Wong, A. O.-T., Wong, G., Shen, M., Chow, M. Z.-Y., Tse, W. W., Gurung, B., Mak, S. Y., Lieu, D. K., Costa, K. D., Chan, C. W., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1305-y · Cited by 27
“Using hvCAS, we measured cellular action potential parameters and electrical conduction as a syncytium, and with 3D human ventricular cardiac tissue strips (hvCTS) that resemble cardiac trabecular muscles [16, 20, 21], we evaluated contractility.”
Self-citationSalem, T. T., Frankman, Z. D., & Churko, J. M. (2022) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2021.0088 · Cited by 28
Tissue-engineered heart chambers as a platform technology for drug discovery and disease modeling
Mousavi, A., Stefanek, E., Jafari, A., Ajji, Z., Naghieh, S., Akbari, M., & Savoji, H. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212916 · Cited by 29
Cardiac Tissue Engineering Models of Inherited and Acquired Cardiomyopathies
Turnbull, I. C., Mayourian, J., Murphy, J. F., Stillitano, F., Ceholski, D. K., & Costa, K. D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8597-5_11 · Cited by 26
“In our hands, human engineered cardiac tissues (hECTs)— capable of recapitulating key aspects of native cardiac muscle physiology [3]—provide a simple yet effective contractility assay to study therapeutic strategies [4], such as stem cell-based cardiotherapies, in the context of healthy [5] and myocyte-depleted [6] c…”
BackgroundSelf-citationContractile behaviors of cardiac muscle cells on mushroom-shaped micropillar arrays
Oyunbaatar, N., Shanmugasundaram, A., & Lee, D. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.10.058 · Cited by 28
Cardiac macrotissues-on-a-plate models for phenotypic drug screens
Meyer, T., Tiburcy, M., & Zimmermann, W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.03.002 · Cited by 32
A New Role for Extracellular Vesicles in Cardiac Tissue Engineering and Regenerative Medicine
Wagner, K. T., & Radisic, M. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100047 · Cited by 27
Cheng, S., Brenière-Letuffe, D., Ahola, V., Wong, A. O. T., Keung, H. Y., Gurung, B., Zheng, Z., Costa, K. D., Lieu, D. K., Keung, W., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106302 · Cited by 23
“Moreover, the construction of tissues, specifically engineered 3D mimics, often necessitates the addition of stromal cells to facilitate proper formation of these tissue constructs.(32,33)”
BackgroundSelf-citationGu, B., Han, K., Cao, H., Huang, X., Li, X., Mao, M., Zhu, H., Cai, H., Li, D., & He, J. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100914 · Cited by 33
(2015) · PubMed · Cited by 23
Jeziorowska, D., Korniat, A., Salem, J., Fish, K. M., & Hulot, J. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1064109 · Cited by 24
“In this approach, iPSC can be mixed with polymeric scaffolds thus allowing the generation of tissue-engineered muscle constructs [76] that can further be transplanted onto the epicardium [77].”
Self-citationMurphy, J. F., Mayourian, J., Stillitano, F., Munawar, S., Broughton, K. M., Agulló-Pascual, E., Sussman, M. A., Hajjar, R. J., Costa, K. D., & Turnbull, I. C. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1486-4 · Cited by 25
Self-citationCardiac Tissue Engineering: Inclusion of Non-cardiomyocytes for Enhanced Features
Munawar, S., & Turnbull, I. C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.653127 · Cited by 20
Self-citationPang, J. K. S., Ho, B. X., Chan, W., & Soh, B.-S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.788955 · Cited by 25
“In addition, drug response studies suggest a limit to EHT achieved maturation (Turnbull et al., 2013).”
BackgroundSeguret, M., Davidson, P. M., Robben, S., Jouve, C., Pereira, C., Lelong, Q., Deshayes, L., Cerveau, C., Berre, M. L., Ribeiro, R. S. R., et al. (2024) · eLife · doi:10.7554/elife.87739 · Cited by 25
Self-citationHuman Induced Pluripotent Stem Cells as a Disease Model System for Heart Failure
Deicher, A., & Seeger, T. (2020) · Current Heart Failure Reports · doi:10.1007/s11897-020-00497-5 · Cited by 23
Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
Cashman, T. J., Josowitz, R., Gelb, B. D., Li, R. A., Dubois, N. C., & Costa, K. D. (2016) · Journal of Visualized Experiments · doi:10.3791/53447-v · Cited by 7
Self-citation
Metadata
- Authors
- Turnbull, I. C., Karakikes, I., Serrao, G. W., Backeris, P., Lee, J., Xie, C., Senyei, G., Gordon, R. E., Li, R. A., Akar, F. G., Hajjar, R. J., Hulot, J., & Costa, K. D.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of Hong Kong (HK)
- Université Pierre-et-Marie-Curie (FR)
- Corresponding author
- Costa, Kevin D.
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2013-10-30
- Volume
- 28
- Issue
- 2
- Pages
- 644-654
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3898643
- OpenAlex
- W2117852513
- Cited by
- 184
- References
- 55
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 13 · 2023: 13 · 2022: 10 · 2021: 17 · 2020: 13 · 2019: 17 · 2018: 13 · 2017: 16 · 2016: 26 · 2015: 24 · 2014: 11
- FWCI
- 19.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Funders
- National Institutes of Health
- National Center for Research Resources
- National Center for Advancing Translational Sciences (UL1RR029887)
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- engineered heart tissue, human embryonic stem cell-derived cardiomyocytes, Frank-Starling mechanism, cardiac electrophysiology, calcium chloride, verapamil, isoproterenol, gene transfer, collagen matrix, optical mapping, cardiac refractoriness, action potential duration
- MeSH terms
- Cell Line, Electrophysiology, Humans, Myocardium, Tissue Engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.